期刊文献+

输尿管癌手术预后的临床病理多因素分析 被引量:5

Multivariate Analysis of Clinicopathological Factors on Ureter Transitional Cell Carcinoma
下载PDF
导出
摘要 目的综合分析和评价临床病理因素对输尿管癌手术预后的影响。方法对手术切除51例输尿管癌7个临床病理因素进行单因素和多因素Cox模型分析。结果单因素分析表明:年龄(P=0.000)、临床分期(P=0.004)、组织学分级(P=0.000)及手术方式(P=0.048)与输尿管癌手术预后显著相关;性别(P=0.655)、肿瘤部位(P=0.245)及病理分级(P=0.092)与输尿管癌手术预后无关。多因素分析表明:临床分期(P=0.021)、组织学分级(P=0.001)、病理分级(P=0.048)及手术方式(P=0.039)是影响输尿管癌手术预后最显著的独立因素。结论在输尿管癌手术术式设计和选择上,更应该重视和强调根治术,在对输尿管癌术后患者预后评估及术后治疗更应该参考临床分期、组织学分级及病理分级。 Objective Our purpose was to evaluate the influence of various clinicopathologic factors on the survival of patients with ureter transitional cell carcinoma(TCC). Methods A computer analysis was performed on 51 patients underwent TCC resection. Results Univariate analysis identified 7 factors that were associated with a significant outcome: Age (P=0.000) , clinical stage (P=0.004) , histologic type of lesion (P=0.000) and the way of surgical operation (P=0.048). The gender (P=0.655) , location of primary lesion (P=-0.245) and pathology type of lesion (P=0.092) were not significantly associated with prognosis. However, when the interactive effects of these factors were taken into account,the clinical stage (P=0.021) , histologic type of lesion (P=0.001) ,pathology type of lesion (P=0.048) and way of surgical operation (P=0.039) were selected as the most significant prognostic factors in a multivariate analysis by using the Cox proportional hazard regression model. Conclusion In ureteral cancer surgery procedures design and choice, more importance should be attached to radical operation. On the prognosis improvement of patients with ureteral carcinoma, postoperative evaluation and treatment should refer to clinical stage, histologic type of lesion and pathology type of lesion.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2013年第12期1163-1166,共4页 Cancer Research on Prevention and Treatment
关键词 输尿管癌 临床病理学 预后 COX模型 Ureter transitional cell carcinoma(TCC) Clinicopathology Prognosis Cox proportional hazard regression model
  • 相关文献

参考文献5

二级参考文献40

  • 1孙羿,何辉,马强,王新阳,杨林,贺大林.膀胱肿瘤抗原和透明质酸等七项肿瘤标志物在膀胱肿瘤诊断中的应用价值[J].中华医学杂志,2005,85(35):2507-2512. 被引量:18
  • 2游瑞雄,李银官,曹代荣,林钊,江飞.多层螺旋CT三维重建对输尿管肿瘤的诊断价值[J].福建医科大学学报,2007,41(2):172-175. 被引量:7
  • 3ORTER C R P, LATCHAMSETTY K C E M. GENEGA, et al. Urothelial neoplasms of the kidney and ureter: an epidemiologic, pathological and clinical revie[J]. AUA Update Series, 2005, 24:77-84.
  • 4Mercedes Marl' n-Aguilera, Lourdes Mengual, Marl'a Jose'Ribal,et al. Utility of fluorescence in situ hybridization as a noninvasive technique in the diagnosis of upper urinary tract urothelial carcinoma[J]. European Urology, 2007,51 : 409-415.
  • 5OEHLSCHLAGER S, BALDAUF A, WIESSNER D, et al. Bladder tumor recurrence after primary surgery for transitional cell carcinoma of the upper urinary tract [J]. Urol Int,2004,73 (3) :209-221.
  • 6CIZTO B, ZIETMAN A,KAUFRMAN D, et a.l Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renalpelvis and ureter[J]. J Urology, 2004, 172 (4): 1271.
  • 7KWAK C, LEE SE, JEONG IG, et al. Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract[J]. Urology, 2006, 68 (1): 53.
  • 8BAMIASAMIASA, DELIVELIOTIS Ch, FOUNTZILASG, et al. 1 Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract., a study by the hellenic cooperative oncology group[J]. J Clin Oncol,2004, 22 (11): 2150.
  • 9YUN SEOB SONG. Adjuvant gemcitabine-cisplatin chemotherapy of invasive transitional cell carcinoma of the upper urinarytract[J].Eui'opean Urology Supptements, 2008,7 (3) : 221.
  • 10Schwartz A,Caine M,Hermann G,et al. Spontaneous renal extravasation during intravenous urography. Am J Roentgenol Radium Ther Nucl Med,1966,98:27-40.

共引文献79

同被引文献50

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部